๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats

โœ Scribed by Hong Wang; Peter T.-H. Wong; Joachim Spiess; Yi Zhun Zhu

Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
315 KB
Volume
29
Category
Article
ISSN
0149-7634

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

CCK1 and 2 receptors are expressed in im
CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: Intracellular signals after cholecystokinin stimulation
โœ Sonja Langmesser; Maria I. Cerezo-Guisado; Maria J. Lorenzo; Luis J. Garcia-Mari ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 303 KB

## Abstract Cholecystokinin (CCK) is one of the most abundant neuropeptides in the central nervous system (CNS) where it promotes important functions by activation of receptors CCK1 and CCK2. Our aim was to investigate CCK receptors expression and their downstream intracellular signaling in immorta

The [Tc(N)(PNP)]2+ metal fragment labele
The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies
โœ Stefania Agostini; Cristina Bolzati; Eliana Didonรจ; Mario Cavazza-Ceccato; Fiore ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

## Abstract The radiolabeling of the natural octapeptide CCK8, derivatized with a cysteine residue (Cysโ€Glyโ€CCK8), by using the metal fragment [^99m^Tc(N)(PNP3)]^2+^ (PNP3 = __N__,__N__โ€bis(dimethoxypropylphosphinoethyl)methoxyethylamine) is reported. The [^99m^Tc(N)(NSโ€Cysโ€Glyโ€CCK8)(PNP3)]^+^ comp

Involvement of septal and striatal dopam
Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats
โœ Katsushi Yamada; Mariko Tanaka; Kazuhiko Shibata; Tatsuo Furukawa ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 561 KB

A behavioral study was performed in an attempt to understand the neuronal mechanisms involved in yawning behavior in rats. Subcutaneous injections of low doses of apomorphine (0.054.25 mg/kg) or piribedil (0.2-1.0 mg/kg), which preferentially activate presynaptic dopamine autoreceptors at those dose